P Nisipeanu
Overview
Explore the profile of P Nisipeanu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
159
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Inzelberg R, Schecthman E, Paleacu D, Zach L, Bonwitt R, Carasso R, et al.
Am J Med Genet A
. 2004 Jan;
124A(3):255-8.
PMID: 14708097
Lately different and rare genetic forms of Parkinson's disease (PD) have been described. Complete genomic screening has suggested that still undefined multiple genetic factors might underlie the development of PD....
2.
Inzelberg R, Hattori N, Nisipeanu P, Abo Mouch S, Blumen S, Carasso R, et al.
Neurology
. 2003 Apr;
60(8):1393-4.
PMID: 12707457
No abstract available.
3.
Inzelberg R, Nisipeanu P, Joel D, Sarkantyus M, Carasso R
Clin Neuropharmacol
. 2001 Oct;
24(5):300-3.
PMID: 11586116
A 61-year-old man suddenly became euphoric and talkative. Later the same day, he developed hemichoreic movements of the left limbs. The patient fulfilled the DSM-IV criteria for a manic episode...
4.
Nisipeanu P, Inzelberg R, Abo Mouch S, Carasso R, Blumen S, Zhang J, et al.
Neurology
. 2001 Jun;
56(11):1573-5.
PMID: 11402119
Autosomal recessive juvenile parkinsonism (AR-JP) is an early-onset parkinsonism caused by exonic deletions or point mutations in the parkingene. The relationship between the type of the genetic defect and the...
5.
A comparison of dopamine agonists and catechol-O-methyltransferase inhibitors in Parkinson's disease
Inzelberg R, Carasso R, Schechtman E, Nisipeanu P
Clin Neuropharmacol
. 2001 Jan;
23(5):262-6.
PMID: 11154093
To compare the efficacy and tolerability of three dopamine agonists--pergolide (PRG), pramipexole (PRX), and ropinirole (ROP)-and two catechol-O-methyltranferase (COMT) inhibitors-tolcapone (TOL) and entacapone (ENT)-as add-on therapies to levodopa (L-Dopa) in...
6.
Inzelberg R, Nisipeanu P, Blumen S, Kovach I, Groisman G, Carasso R
Neurology
. 2001 Jan;
55(12):1934-5.
PMID: 11134404
No abstract available.
7.
Blumen S, Korczyn A, Lavoie H, Medynski S, Chapman J, Asherov A, et al.
Neurology
. 2000 Nov;
55(9):1267-70.
PMID: 11087766
Objective: To determine whether all cases of oculopharyngeal muscular dystrophy (OPMD) among Bukhara Jews share the same founder mutation. Background: Autosomal dominant OPMD is caused by a (GCG)8-13 repeat expansion...
8.
Inzelberg R, Nisipeanu P, Blumen S, Carasso R
J Neurol Neurosurg Psychiatry
. 2000 Feb;
68(1):103-4.
PMID: 10671116
No abstract available.
9.
Preliminary observations on APOE epsilon4 allele and progression of disability in multiple sclerosis
Chapman J, Sylantiev C, Nisipeanu P, Korczyn A
Arch Neurol
. 1999 Dec;
56(12):1484-7.
PMID: 10593303
Background: Apolipoprotein E expression is increased in regenerating neural tissue and the APOE epsilon4 allele is associated with impaired neuronal repair. Since repair is essential for the restoration of central...
10.
Nisipeanu P, Inzelberg R, Blumen S, Carasso R, Hattori N, Matsumine H, et al.
Neurology
. 1999 Oct;
53(7):1602-4.
PMID: 10534280
We report a Jewish family of Yemenite origin in which three brothers born from a consanguineous marriage had juvenile parkinsonism. The DNA samples from three affected brothers and one healthy...